Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Emphysema |
French
|
Emphysรจme |
| Level | Code | Title | |
|---|---|---|---|
| 1 | X | Diseases of the respiratory system | |
| 2 | J40-J47 | Chronic lower respiratory diseases | |
| 3 | J43 | Emphysema |
| Code | Title | |
|---|---|---|
| J43.0 | MacLeod's syndrome | |
| J43.1 | Panlobular emphysema | |
| J43.2 | Centrilobular emphysema | |
| J43.8 | Other emphysema | |
| J43.9 | Emphysema, unspecified |
| Active Ingredient | Description | |
|---|---|---|
| Ipratropium |
Ipratropium is a quaternary ammonium compound with anticholinergic (parasympatholytic) properties. Ipratropium appears to inhibit vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++, which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. Ca++ release is mediated by the second messenger system consisting of IP3 (inositol triphosphate) and DAG (diacylglycerol). |
|
| Metaproterenol |
Orciprenaline sulphate is a bronchodilating agent. The bronchospasm associated with various pulmonary diseases-chronic bronchitis, pulmonary emphysema, bronchial asthma, silicosis, tuberculosis, sarcoidosis and carcinoma of the lung, has been successfully reversed by therapy with orciprenaline sulphate. |
|
| Salbutamol |
Salbutamol is a selective ฮฒ2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the ฮฒ2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases. |
